X

Bruker Corp (BRKR) Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

Bruker Corp (NASDAQ: BRKR) FY 2026 Product Release

Newsdesk: